{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:37:25Z","timestamp":1783953445295,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06143-1","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T08:19:31Z","timestamp":1753345171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gavage versus dietary adenine administration is more effective for the female mouse model of chronic kidney disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Ver\u00f3nica","family":"Vi\u00f1uela-Berni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Antonieta","family":"Carbajo-Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1539-2070","authenticated-orcid":false,"given":"Teresa","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"6143_CR1","doi-asserted-by":"publisher","unstructured":"Lim, D. K. E. et al. Prediction models used in the progression of chronic kidney disease: A scoping review. PLoS ONE vol. 17 Preprint at (2022). https:\/\/doi.org\/10.1371\/journal.pone.0271619","DOI":"10.1371\/journal.pone.0271619"},{"key":"6143_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov, B. et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"6143_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.pop.2020.08.001","volume":"47","author":"CF CHARLES","year":"2020","unstructured":"CHARLES, C. F. A. H. Chronic kidney disease. Prim. Care: Clin. Office Pract. 47, 585\u2013595 (2020).","journal-title":"Prim. Care: Clin. Office Pract."},{"key":"6143_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65398","author":"P Shende","year":"2024","unstructured":"Shende, P. et al. A study of abnormal echocardiogram findings in patients with chronic kidney disease with reference to cardiac biomarkers. Cureus https:\/\/doi.org\/10.7759\/cureus.65398 (2024).","journal-title":"Cureus"},{"key":"6143_CR5","doi-asserted-by":"crossref","unstructured":"Hayeeawaema, F. et al. A novel model of adenine-induced chronic kidney disease-associated gastrointestinal dysfunction in mice: the gut-kidney axis. Saudi J. Biol. Sci 30, 103660 (2023).","DOI":"10.1016\/j.sjbs.2023.103660"},{"key":"6143_CR6","doi-asserted-by":"publisher","unstructured":"Corona, R., Ordaz, B., Robles-Osorio, L., Sabath, E. & Morales, T. Neuroimmunoendocrine Link Between Chronic Kidney Disease and Olfactory Deficits. Frontiers in Integrative Neuroscience vol. 16 Preprint at (2022). https:\/\/doi.org\/10.3389\/fnint.2022.763986","DOI":"10.3389\/fnint.2022.763986"},{"key":"6143_CR7","unstructured":"Wouk, N. End-Stage Renal Disease: Medical Management. vol. 104 www. (2021). aafp.org\/afp"},{"key":"6143_CR8","doi-asserted-by":"crossref","unstructured":"Hamzaoui, M. et al. 5\/6 nephrectomy induces different renal, cardiac and vascular consequences in 129\/sv and C57BL\/6JRj mice. Sci Rep 10, 1524 (2020).","DOI":"10.1038\/s41598-020-58393-w"},{"key":"6143_CR9","doi-asserted-by":"publisher","unstructured":"Kim, K. et al. Skeletal myopathy in CKD: A comparison of adenine-induced nephropathy and 5\/6 nephrectomy models in mice. Am. J. Physiol. - Ren. Physiol. 321 https:\/\/doi.org\/10.1152\/AJPRENAL.00117.2021 (2021). F106\u2013F119 Preprint at.","DOI":"10.1152\/AJPRENAL.00117.2021"},{"key":"6143_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1681\/ASN.2019080827","volume":"31","author":"BM Klinkhammer","year":"2020","unstructured":"Klinkhammer, B. M. et al. Cellular and molecular mechanisms of kidney injury in 2,8-dihydroxyadenine nephropathy. J. Am. Soc. Nephrol. 31, 799\u2013816 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"6143_CR11","doi-asserted-by":"publisher","unstructured":"Yang, Q., Su, S., Luo, N. & Cao, G. Adenine-induced animal model of chronic kidney disease: current applications and future perspectives. Renal Failure vol. 46 Preprint at (2024). https:\/\/doi.org\/10.1080\/0886022X.2024.2336128","DOI":"10.1080\/0886022X.2024.2336128"},{"key":"6143_CR12","unstructured":"Achterberg, P. W. Adenine NucIeotides, Purine Metabolism and Myocardial Function."},{"key":"6143_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/prot.1093","volume":"44","author":"KA Denessiouk","year":"2001","unstructured":"Denessiouk, K. A., Rantanen, V. V. & Johnson, M. S. Adenine recognition: A motif present in ATP-, CoA-, NAD-, NADP-, and FAD-dependent proteins. Proteins: Struct. Function Genet. 44, 282\u2013291 (2001).","journal-title":"Proteins: Struct. Function Genet."},{"key":"6143_CR14","unstructured":"Kamatani, N. et al. Severe Impairment in Adenine Metabolism With a Partial Deficiency of Adenine Phosphoribosyltransferase."},{"key":"6143_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jn\/114.4.753","volume":"114","author":"LM Salati","year":"1984","unstructured":"Salati, L. M. Absorption and metabolism of adenine, adenosine-5\u2019-monophosphate, adenosine and hypoxanthine by the isolated vascularly perfused rat small intestine. J. Nutr. 114, 753\u2013760 (1984).","journal-title":"J. Nutr."},{"key":"6143_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lfs.2016.07.020","volume":"161","author":"MK Mazumder","year":"2016","unstructured":"Mazumder, M. K., Giri, A., Kumar, S. & Borah, A. A highly reproducible mice model of chronic kidney disease: evidences of behavioural abnormalities and blood-brain barrier disruption. Life Sci. 161, 27\u201336 (2016).","journal-title":"Life Sci."},{"key":"6143_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nep.13180","volume":"23","author":"V Diwan","year":"2018","unstructured":"Diwan, V., Brown, L. & Gobe, G. C. Adenine-induced chronic kidney disease in rats. Nephrology 23, 5\u201311 (2018). https:\/\/doi.org\/10.1111\/nep.13180 Preprint at.","journal-title":"Nephrology"},{"key":"6143_CR18","doi-asserted-by":"crossref","unstructured":"Yokozawa, T., Zheng, P. D., Oura, H. & Koizumi, F. Animal model of adenine-induced chronic renal failure in rats. Nephron, 44, 230\u2013234 (1986).","DOI":"10.1159\/000183992"},{"key":"6143_CR19","doi-asserted-by":"crossref","unstructured":"Rahman, A. et al. A novel approach to adenine-induced chronic kidney disease associated anemia in rodents. PLoS One 13, e0192531 (2018).","DOI":"10.1371\/journal.pone.0192531"},{"key":"6143_CR20","doi-asserted-by":"crossref","unstructured":"Pang, Q. et al. Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease. Cell Death Dis 13, 283 (2022).","DOI":"10.1038\/s41419-022-04735-7"},{"key":"6143_CR21","doi-asserted-by":"crossref","unstructured":"Zhou, S. et al. Ophiocordyceps lanpingensis polysaccharides alleviate chronic kidney disease through MAPK\/NF-\u03baB pathway. J Ethnopharmacol 276, 114189 (2021).","DOI":"10.1016\/j.jep.2021.114189"},{"key":"6143_CR22","doi-asserted-by":"crossref","unstructured":"Makhloufi, C. et al. Female ahr knockout mice develop a minor renal insufficiency in an adenine-diet model of chronic kidney disease. Int J. Mol. Sci 21, 2483 (2020).","DOI":"10.3390\/ijms21072483"},{"key":"6143_CR23","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1172\/JCI135773","volume":"130","author":"YH Chou","year":"2020","unstructured":"Chou, Y. H. et al. Methylation in pericytes after acute injury promotes chronic kidney disease. J. Clin. Invest. 130, 4845\u20134857 (2020).","journal-title":"J. Clin. Invest."},{"key":"6143_CR24","doi-asserted-by":"crossref","unstructured":"Scherler, L., Verouti, S. N., Ackermann, D., Vogt, B. & Escher, G. Adenine-Induced Nephropathy Reduces Atherosclerosis in ApoE Knockout Mice. Biomolecules 12, (2022).","DOI":"10.3390\/biom12081147"},{"key":"6143_CR25","doi-asserted-by":"crossref","unstructured":"Barba, C. et al. A low aromatic amino-acid diet improves renal function and prevent kidney fibrosis in mice with chronic kidney disease. Sci Rep 11, 19184 (2021).","DOI":"10.1038\/s41598-021-98718-x"},{"key":"6143_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.vascn.2018.04.003","volume":"94","author":"CZ Zhu","year":"2018","unstructured":"Zhu, C. Z. et al. Short-term oral gavage administration of adenine induces a model of fibrotic kidney disease in rats. J. Pharmacol. Toxicol. Methods. 94, 34\u201343 (2018).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"6143_CR27","doi-asserted-by":"crossref","unstructured":"Zhou, M. et al. Adenine\u2019s impact on mice\u2019s gut and kidney varies with the dosage administered and relates to intestinal microorganisms and enzyme activities. 3 Biotech 14, (2024).","DOI":"10.1007\/s13205-024-03959-y"},{"key":"6143_CR28","doi-asserted-by":"crossref","unstructured":"Pan, J., Shi, M., Guo, F., Ma, L. & Fu, P. Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease. Life Sci 285, 119946 (2021).","DOI":"10.1016\/j.lfs.2021.119946"},{"key":"6143_CR29","doi-asserted-by":"crossref","unstructured":"Dargam, V. et al. Sex-Specific changes in cardiac function and electrophysiology during progression of Adenine-Induced chronic kidney disease in mice. J Cardiovasc. Dev. Dis 11, 362 (2024).","DOI":"10.3390\/jcdd11110362"},{"key":"6143_CR30","doi-asserted-by":"crossref","unstructured":"Rodrigues, W. F., Miguel, C. B., Napimoga, M. H., Oliveira, C. J. F. & Lazo-Chica, J. E. Establishing Standards for Studying Renal Function in Mice through Measurements of Body Size-Adjusted Creatinine and Urea Levels. Biomed Res Int (2014). (2014).","DOI":"10.1155\/2014\/872827"},{"key":"6143_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.kint.2019.02.016","volume":"96","author":"G Schley","year":"2019","unstructured":"Schley, G. et al. Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis. Kidney Int. 96, 378\u2013396 (2019).","journal-title":"Kidney Int."},{"key":"6143_CR32","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3109\/0886022X.2011.618906","volume":"33","author":"Y Morishita","year":"2011","unstructured":"Morishita, Y., Ohnishi, A., Watanabe, M., Ishibashi, K. & Kusano, E. Establishment of acute kidney injury mouse model by 0.75% adenine ingestion. Ren. Fail. 33, 1013\u20131018 (2011).","journal-title":"Ren. Fail."},{"key":"6143_CR33","doi-asserted-by":"crossref","unstructured":"Cui, D. et al. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Phytomedicine 66, 153111 (2020).","DOI":"10.1016\/j.phymed.2019.153111"},{"key":"6143_CR34","doi-asserted-by":"crossref","unstructured":"Jia, T. et al. A novel model of adenine-induced tubulointerstitial nephropathy in mice. BMC Nephrol 14, 116 (2013).","DOI":"10.1186\/1471-2369-14-116"},{"key":"6143_CR35","doi-asserted-by":"publisher","unstructured":"Kashani, K., Rosner, M. H., Ostermann, M. & Creatinine From physiology to clinical application. European Journal of Internal Medicine vol. 72 9\u201314 Preprint at (2020). https:\/\/doi.org\/10.1016\/j.ejim.2019.10.025","DOI":"10.1016\/j.ejim.2019.10.025"},{"key":"6143_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.endinu.2019.12.008","volume":"67","author":"CAA Diago","year":"2020","unstructured":"Diago, C. A. A. A. A. \u00bfDebemos prestar m\u00e1s atenci\u00f3n a la creatinina baja? Endocrinolog\u00eda Diabetes Y Nutrici\u00f3n. 67, 486\u2013492 (2020).","journal-title":"Endocrinolog\u00eda Diabetes Y Nutrici\u00f3n"},{"key":"6143_CR37","doi-asserted-by":"crossref","unstructured":"Wang, H. R. Urea. in Urea Transporters. Subcellular Biochemistry (eds Yang, B., Jeff, M. & Sands) vol. 73 Springer, 179\u2013191 (2014).","DOI":"10.1007\/978-94-017-9343-8"},{"key":"6143_CR38","first-page":"303","volume":"7","author":"L Succar","year":"2014","unstructured":"Succar, L., Lai-Kwon, J., Nikolic-Paterson, D. J. & Rangan, G. K. Induction monotherapy with sirolimus has selected beneficial effects on glomerular and tubulointersititial injury in nephrotoxic serum nephritis. Int. J. Nephrol. Renovasc Dis. 7, 303\u2013313 (2014).","journal-title":"Int. J. Nephrol. Renovasc Dis."},{"key":"6143_CR39","unstructured":"Gilbert, S. F. National Kidney Foundation Primer on Kidney Diseases,E-Book (Elsevier Health Sciences, 2022)."},{"key":"6143_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1152\/ajpregu.00383.2013","volume":"306","author":"A Saeed","year":"2014","unstructured":"Saeed, A. et al. High-NaCl diet impairs dynamic renal blood flow autoregulation in rats with adenine-induced chronic renal failure. J. Physiol. Regul. Integr. Comp. Physiol. 306, 411\u2013419 (2014).","journal-title":"J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"6143_CR41","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-M\u00e9ndez, E. et al. Recombinant erythropoietin provides protection against renal fibrosis in adenine-induced chronic kidney disease. Mediators Inflamm. 2020, 8937657 (2020).","DOI":"10.1155\/2020\/8937657"},{"key":"6143_CR42","doi-asserted-by":"crossref","unstructured":"Panditrao Lahane, G. & Dhar, A. Renoprotective effect of Nesfatin-1 in Adenine-Induced chronic kidney disease: an in vitro and in vivo study. Biochem Pharmacol 225, 116284 (2024).","DOI":"10.1016\/j.bcp.2024.116284"},{"key":"6143_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/sdi.13030","volume":"37","author":"A Biruete","year":"2024","unstructured":"Biruete, A., Shin, A., Kistler, B. M. & Moe, S. M. Feeling gutted in chronic kidney disease (CKD): gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis. Semin Dial. 37, 334\u2013349 (2024).","journal-title":"Semin Dial"},{"key":"6143_CR44","doi-asserted-by":"crossref","unstructured":"Hoibian, E., Florens, N., Koppe, L., Vidal, H. & Soulage, C. O. Distal colon motor dysfunction in mice with chronic kidney disease: putative role of uremic toxins. Toxins (Basel) 10, 204 (2018).","DOI":"10.3390\/toxins10050204"},{"key":"6143_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00508-022-02074-3","volume":"135","author":"MJ Lewandowski","year":"2023","unstructured":"Lewandowski, M. J. et al. Chronic kidney disease is more prevalent among women but more men than women are under nephrological care: analysis from six outpatient clinics in austria 2019. Wien Klin. Wochenschr. 135, 89\u201396 (2023).","journal-title":"Wien Klin. Wochenschr"},{"key":"6143_CR46","doi-asserted-by":"crossref","unstructured":"Fanelli, C., Dell\u00ea, H., Cavaglieri, R. C., Dominguez, W. V. & Noronha, I. L. Gender differences in the progression of experimental chronic kidney disease induced by chronic nitric oxide inhibition. Biomed Res Int (2017). (2017).","DOI":"10.1155\/2017\/2159739"},{"key":"6143_CR47","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens, P. E. et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"key":"6143_CR48","doi-asserted-by":"publisher","first-page":"e0311902","DOI":"10.1371\/journal.pone.0311902","volume":"19","author":"Y Mizukami","year":"2024","unstructured":"Mizukami, Y. et al. Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice. PLoS One. 19, e0311902 (2024).","journal-title":"PLoS One"},{"key":"6143_CR49","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.vascn.2013.05.001","volume":"68","author":"BH Ali","year":"2013","unstructured":"Ali, B. H. et al. New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats. J. Pharmacol. Toxicol. Methods. 68, 384\u2013393 (2013).","journal-title":"J. Pharmacol. Toxicol. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06143-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:28:07Z","timestamp":1757280487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06143-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6143"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06143-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26905"}}